TRVI

Business

Analysts’ expectations for Trevi Therapeutics Inc (TRVI) stock: $8 price target in 12 months

Ulysses Smith

At the time of writing, Trevi Therapeutics Inc [TRVI] stock is trading at $10.19, up 4.94%. In order to assess ...

Business

Growth and Margin Analysis of Trevi Therapeutics Inc (TRVI)’s Recent Quarter Sales

Ulysses Smith

At the time of writing, Trevi Therapeutics Inc [TRVI] stock is trading at $9.88, up 3.35%. One of the good ...

MZP News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.